Literature DB >> 3539393

Selection of patients for cardiac transplantation.

J G Copeland, R W Emery, M M Levinson, T B Icenogle, M Carrier, R A Ott, J A Copeland, M J McAleer-Rhenman, S M Nicholson.   

Abstract

Selection of potential cardiac recipients is not a simple process. Identification of patients who are declining from end-stage cardiac disease and may be expected to die within 12 months or less and deciding which of a number of cardiac invalids are reasonable candidates for cardiac transplantation involves prognostication as well as a working knowledge of the expected benefits and survival rates in cardiac transplantation. Screening by means of the currently accepted contraindications for cardiac transplantation is somewhat more difficult in 1986 than it was 10 years ago when these contraindications were changing less rapidly. However, for optimal use of the limited supply of donor organs and maintenance of reasonable survival rates such screening is absolutely necessary. A second area of restriction that is less approachable by the physician is that of financial limitations. It would appear that the working poor and lower middle class may be deprived of the opportunity for cardiac transplantation much as they are deprived of the opportunity for optimal medical care in our society today.

Entities:  

Keywords:  Arizona Health Sciences Center; Health Care and Public Health; Medicaid; Professional Patient Relationship

Mesh:

Year:  1987        PMID: 3539393     DOI: 10.1161/01.cir.75.1.2

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Cardiac transplantation--the need for prospective, randomized, controlled investigations.

Authors:  D G Renlund; M R Bristow; J B O'Connell
Journal:  West J Med       Date:  1988-11

Review 2.  Treatment of congestive heart failure--state of the art and future trends.

Authors:  W W Parmley
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

3.  Chronic respiratory illness as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S A Martin; S S Coughlin; C Metayer; A A René; I W Hammond
Journal:  J Natl Med Assoc       Date:  1996-11       Impact factor: 1.798

4.  Impact of donor left ventricular hypertrophy on survival after heart transplant.

Authors:  O Wever Pinzon; G Stoddard; S G Drakos; E M Gilbert; J N Nativi; D Budge; F Bader; R Alharethi; B Reid; C H Selzman; M D Everitt; A G Kfoury; J Stehlik
Journal:  Am J Transplant       Date:  2011-09-11       Impact factor: 8.086

5.  Successful transplantation of marginally acceptable thoracic organs.

Authors:  I L Kron; C G Tribble; J A Kern; T M Daniel; C E Rose; J D Truwit; L H Blackbourne; J D Bergin
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

6.  Barriers to cardiac transplantation in idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study.

Authors:  S S Coughlin; S Halabi; C Metayer
Journal:  J Natl Med Assoc       Date:  1998-06       Impact factor: 1.798

7.  Pre-transplant malignancy: an analysis of outcomes after thoracic organ transplantation.

Authors:  Claude A Beaty; Timothy J George; Arman Kilic; John V Conte; Ashish S Shah
Journal:  J Heart Lung Transplant       Date:  2012-12-21       Impact factor: 10.247

8.  Sleeve Gastrectomy and Left Ventricular Assist Device for Heart Transplant.

Authors:  Joseph Greene; Tung Tran; Timothy Shope
Journal:  JSLS       Date:  2017 Jul-Sep       Impact factor: 2.172

9.  National Trends In Kidney, Heart And Liver Transplants Among Patients With And Without Chronic Obstructive Pulmonary Disease In Spain (2001-2015).

Authors:  Javier de Miguel-Díez; Rodrigo Jiménez-García; Valentín Hernández-Barrera; José M de Miguel-Yanes; Manuel Méndez-Bailón; Ana López-de-Andres
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.